Shares of Tenax Therapeutics Inc. (TENX) are surging over 72% in pre-market today, after the specialty pharmaceutical company announced positive Phase 2 results for levosimendan for the treatment of patients with pulmonary hypertension and heart failure with preserved ejection fraction.
from RTT - Before the Bell https://ift.tt/3gJAwn7
via IFTTT
No comments:
Post a Comment